Phase I trial of EOS 100850 for safety and efficacy.
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2018
At a glance
- Drugs EOS-100850 (Primary)
- Indications Cancer
- Focus Adverse reactions
- 20 Jun 2018 According to iTeos Therapeutics media release, this trial is expected to begin in the second half of 2018.
- 14 Feb 2018 New trial record
- 09 Feb 2018 According to iTeos Therapeutics media release, trial expected to begin in 2018